pharmaceuticals-and-healthcare

Global Pediatric Drugs and Vaccines Market Insights, Forecast to 2025


Published On : Sep 2018

Category : Pharmaceutical

No. of Pages : 121 pages

  • $3900
  • $7800

SPECIFY YOUR RESEARCH NEED

  • Query Type :
  •  
This report studies the global market size of Pediatric Drugs and Vaccines in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pediatric Drugs and Vaccines in these regions.
This research report categorizes the global Pediatric Drugs and Vaccines market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Children differ from adults in many aspects of pharmacotherapy, including capabilities for drug administration, medicine-related toxicity, and taste preferences. It is essential that pediatric medicines are formulated to best suit a child's age, size, physiologic condition, and treatment requirements. Therefore, the pediatric drug and vasccines specially serve for children.
In 2017, the global Pediatric Drugs and Vaccines market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Pediatric Drugs and Vaccines market based on company, product type, application and key regions.

The various contributors involved in the value chain of Pediatric Drugs and Vaccines include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Pediatric Drugs and Vaccines include
Merck & Co., Inc. (USA)
Abbott Laboratories (USA)
Amgen, Inc. (USA)
Eli Lilly and Company (USA)
F. Hoffmann-La Roche Ltd (Switzerland)
Genentech, Inc. (USA)
GlaxoSmithKline plc. (UK)
Janssen Biologics B.V. (USA)
Actelion Pharmaceuticals
AstraZeneca Plc. (UK)
Boehringer Ingelheim GmbH (Germany)
Bristol-Myers Squibb Company (USA)
Allergan, Inc. (USA)
Novartis AG (Switzerland)
Novo Nordisk A/S (Denmark)
Pfizer, Inc. (USA)
Sanofi S.A (France)
Shionogi Inc. (USA)
Shire Pharmaceuticals Group Plc. (UK)

Market Size Split by Type
Diphtheria
Influenza
Hepatitis
Pneumococcal Diseases
Meningococcal Diseases
Mumps
Others
Market Size Split by Application
Newborn
Infant
Child

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Pediatric Drugs and Vaccines market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Pediatric Drugs and Vaccines market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Pediatric Drugs and Vaccines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Pediatric Drugs and Vaccines with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Pediatric Drugs and Vaccines submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Pediatric Drugs and Vaccines are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pediatric Drugs and Vaccines market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

In the recent times, the global market for Global pediatric drugs and vaccines market insights forecast to 2025 has surfaced as one of the most promising markets in the pharmaceutical industry, thanks to the significant rise in research and development activities by leading vendors of Global pediatric drugs and vaccines market insights forecast to 2025 across the world. Manufacturers have turned to technological innovations and data-driven customization to satisfy the augmenting consumer demand for efficiency and more accuracy in results, leading to an increased usage of technology in the Global pediatric drugs and vaccines market insights forecast to 2025 production processes, which is also reflecting positively on the growth of this market.

The research report on the Global pediatric drugs and vaccines market insights forecast to 2025 is an analytical study which comprehensively analyzes the competitive framework of this market. Using a number of effective assessment tools, such as porter’s five forces and value chain analysis, it performs in-depth analyses of the production and supply as well as the demand and sales of Global pediatric drugs and vaccines market insights forecast to 2025 and provides deep insights into the future prospects of this market.

The study begins with a detailed overview of the market for Global pediatric drugs and vaccines market insights forecast to 2025, including the definition, classification, and industry chain structure of Global pediatric drugs and vaccines market insights forecast to 2025, and move forward to cover every aspect of this market, counting several criteria based on which the market is classified. Focusing specifically on the key trends, it further evaluates the overall performance of this market during the assessment period. With chemical industry undergoing a phase of technological disruption, innovations in products are likely to shape the future of the Global pediatric drugs and vaccines market insights forecast to 2025.

In this research report, apart from the trends, the driving forces, restraints, and opportunities have also been taken into consideration to determine the market’s future. Further, it offers an estimation of the market size in terms of value (US$) and in volume (kilo tons) and talks about the key segments and the geographical subdivisions of the market for Global pediatric drugs and vaccines market insights forecast to 2025 in details. It provides in-depth information on the development trends and the policies and regulations, concerning Global pediatric drugs and vaccines market insights forecast to 2025, implemented in each of the geographical segments. The predominant applications of the Global pediatric drugs and vaccines market insights forecast to 2025 have also been discussed at length in this research study.

With all these analyses and information, this report can act as a valuable guide to readers looking to gain a clear understanding of all the factors that are influencing the market for Global pediatric drugs and vaccines market insights forecast to 2025 at present and are projected to remain doing so over the forecast period. Readers will also benefit significantly from the important information regarding this market, provided in the forms of figures and tables in the research report.

Additionally, the information on the latest developments in this market, both, at the global as well as regional level, is expected to enhance the decision-making capability of the reader. Up-to-date information on various specifications, buyer analysis, their purchasing volume, prices, and price analysis, and deep insights on the leading suppliers have also been provided in this study for the readers.

At last, the report offers key industry recommendations to companies looking to venture into the Global pediatric drugs and vaccines market insights forecast to 2025 from both the perspectives, i.e. demand and supply. The main objective of this research study is to assist stakeholders operating in this market in creating efficient counter strategies to gain an edge over their competitors.

List of Tables and Figures

Figure Picture of Pediatric Drugs and Vaccines
Figure Global Pediatric Drugs and Vaccines Production (MT) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Pediatric Drugs and Vaccines Production Market Share by Types (Product Category) in 2017
Figure Diphtheria Product Picture
Table Major Manufacturers of Diphtheria
Figure Influenza Product Picture
Table Major Manufacturers of Influenza
Figure Hepatitis Product Picture
Table Major Manufacturers of Hepatitis
Figure Pneumococcal Diseases Product Picture
Table Major Manufacturers of Pneumococcal Diseases
Figure Meningococcal Diseases Product Picture
Table Major Manufacturers of Meningococcal Diseases
Figure Mumps Product Picture
Table Major Manufacturers of Mumps
Figure Others Product Picture
Table Major Manufacturers of Others
Table Global Pediatric Drugs and Vaccines Market Size Growth Rate by Application 2018-2025 (MT)
Figure Newborn
Figure Infant
Figure Child
Figure Pediatric Drugs and Vaccines Report Years Considered
Figure Global Pediatric Drugs and Vaccines Market Size 2016-2025 (Million US$)
Figure Global Pediatric Drugs and Vaccines Sales 2016-2025 (MT)
Table Global Pediatric Drugs and Vaccines Market Size by Regions 2016-2025 (MT) & (Million US$)
Table Global Pediatric Drugs and Vaccines Sales by Regions 2016-2025 (MT)
Table Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2016-2025
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Regions 2016-2025
Figure 2017 Global Pediatric Drugs and Vaccines Sales Market Share by Regions
Table Global Pediatric Drugs and Vaccines Revenue by Regions 2016-2025 (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2016-2025
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Regions 2016-2025
Figure 2017 Global Pediatric Drugs and Vaccines Revenue Market Share by Regions
Table Global Pediatric Drugs and Vaccines Sales by Manufacturers (2016-2018) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Manufacturers (2016-2018)
Figure Global Pediatric Drugs and Vaccines Sales Share by Manufacturers in 2017
Table Pediatric Drugs and Vaccines Revenue by Manufacturers (2016-2018) (Million US$)
Table Pediatric Drugs and Vaccines Revenue Share by Manufacturers (2016-2018)
Figure Pediatric Drugs and Vaccines Value Share by Manufacturers in 2017
Table Global Pediatric Drugs and Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Pediatric Drugs and Vaccines Price (2016-2018) (USD/Kg)
Table Pediatric Drugs and Vaccines Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pediatric Drugs and Vaccines Product Category
Table Date of International Manufacturers Enter into Pediatric Drugs and Vaccines Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Type (2016-2025)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure Global Pediatric Drugs and Vaccines Sales Market Share by Type in 2017
Table Global Pediatric Drugs and Vaccines Revenue by Type (2016-2025) (Million US$)
Table Global Pediatric Drugs and Vaccines Revenue Share by Type (2016-2025)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Type (2016-2025)
Figure Global Pediatric Drugs and Vaccines Revenue Market Share by Type in 2017
Table Pediatric Drugs and Vaccines Price by Type 2013-2018 (USD/Kg)
Table Global Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table Global Pediatric Drugs and Vaccines Sales Share by Application (2016-2025)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by Application (2016-2025)
Figure Global Sales Pediatric Drugs and Vaccines Market Share by Application (2016-2025)
Figure North America Pediatric Drugs and Vaccines Sales Growth Rate 2016-2025 (MT)
Figure North America Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table North America Pediatric Drugs and Vaccines Sales by Countries (2016-2025) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 North America Pediatric Drugs and Vaccines Sales Market Share by Countries
Table North America Pediatric Drugs and Vaccines Revenue by Countries (2016-2025) (Million US$)
Table North America Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure United States Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure United States Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Canada Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Mexico Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table North America Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 North America Pediatric Drugs and Vaccines Market Share by Type
Table North America Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 North America Pediatric Drugs and Vaccines Market Share by Application
Table North America Pediatric Drugs and Vaccines Sales by Company (2016-2018) (MT)
Table North America Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2018)
Figure North America Pediatric Drugs and Vaccines Sales Market Share by Company in 2017
Figure Europe Pediatric Drugs and Vaccines Sales Growth Rate 2016-2025 (MT)
Figure Europe Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Pediatric Drugs and Vaccines Sales by Countries (2016-2025) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Europe Pediatric Drugs and Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure Germany Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Germany Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (MT)
Figure France Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure France Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (MT)
Figure UK Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure UK Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Italy Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Russia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Europe Pediatric Drugs and Vaccines Market Share by Type
Table Europe Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Europe Pediatric Drugs and Vaccines Market Share by Application
Table Europe Pediatric Drugs and Vaccines Sales by Company (2016-2018) (MT)
Table Europe Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2018)
Figure Europe Pediatric Drugs and Vaccines Sales Market Share by Company in 2017
Figure Asia Pacific Pediatric Drugs and Vaccines Sales Growth Rate 2016-2025 (MT)
Figure Asia Pacific Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Countries (2016-2025) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Asia Pacific Pediatric Drugs and Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure China Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure China Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Japan Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Korea Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure India Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure India Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Australia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Indonesia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Malaysia Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Philippines Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Thailand Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Vietnam Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Singapore Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Pediatric Drugs and Vaccines Market Share by Type
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Pediatric Drugs and Vaccines Market Share by Application
Table Asia Pacific Pediatric Drugs and Vaccines Sales by Company (2016-2018) (MT)
Table Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2018)
Figure Asia Pacific Pediatric Drugs and Vaccines Sales Market Share by Company in 2017
Figure Central & South America Pediatric Drugs and Vaccines Sales Growth Rate 2016-2025 (MT)
Figure Central & South America Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Sales by Countries (2016-2025) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Central & South America Pediatric Drugs and Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure Brazil Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Brazil Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Argentina Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Pediatric Drugs and Vaccines Market Share by Type
Table Central & South America Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Pediatric Drugs and Vaccines Market Share by Application
Table Central & South America Pediatric Drugs and Vaccines Sales by Company (2016-2018) (MT)
Table Central & South America Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2018)
Figure Central & South America Pediatric Drugs and Vaccines Sales Market Share by Company in 2017
Figure Middle East and Africa Pediatric Drugs and Vaccines Sales Growth Rate 2016-2025 (MT)
Figure Middle East and Africa Pediatric Drugs and Vaccines Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Countries (2016-2025) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Countries
Table Middle East and Africa Pediatric Drugs and Vaccines Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Pediatric Drugs and Vaccines Revenue Market Share by Countries
Figure GCC Countries Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure GCC Countries Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Turkey Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure Egypt Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Pediatric Drugs and Vaccines Sales Growth Rate (2016-2025) (MT)
Figure South Africa Pediatric Drugs and Vaccines Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Type (2016-2025) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Pediatric Drugs and Vaccines Market Share by Type
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Application (2016-2025) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Pediatric Drugs and Vaccines Market Share by Application
Table Middle East and Africa Pediatric Drugs and Vaccines Sales by Company (2016-2018) (MT)
Table Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Pediatric Drugs and Vaccines Sales Market Share by Company in 2017
Table Merck & Co., Inc. (USA) Company Details
Table Merck & Co., Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Merck & Co., Inc. (USA) Recent Development
Table Abbott Laboratories (USA) Company Details
Table Abbott Laboratories (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Abbott Laboratories (USA) Recent Development
Table Amgen, Inc. (USA) Company Details
Table Amgen, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Amgen, Inc. (USA) Recent Development
Table Eli Lilly and Company (USA) Company Details
Table Eli Lilly and Company (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Eli Lilly and Company (USA) Recent Development
Table F. Hoffmann-La Roche Ltd (Switzerland) Company Details
Table F. Hoffmann-La Roche Ltd (Switzerland) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table F. Hoffmann-La Roche Ltd (Switzerland) Recent Development
Table Genentech, Inc. (USA) Company Details
Table Genentech, Inc. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Genentech, Inc. (USA) Recent Development
Table GlaxoSmithKline plc. (UK) Company Details
Table GlaxoSmithKline plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table GlaxoSmithKline plc. (UK) Recent Development
Table Janssen Biologics B.V. (USA) Company Details
Table Janssen Biologics B.V. (USA) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Janssen Biologics B.V. (USA) Recent Development
Table Actelion Pharmaceuticals Company Details
Table Actelion Pharmaceuticals Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table Actelion Pharmaceuticals Recent Development
Table AstraZeneca Plc. (UK) Company Details
Table AstraZeneca Plc. (UK) Pediatric Drugs and Vaccines Sales (MT), Revenue (Million US$), Price (USD/Kg) and Gross Margin (2016-2018)
Table AstraZeneca Plc. (UK) Recent Development
Table Boehringer Ingelheim GmbH (Germany) Company Details
Table Bristol-Myers Squibb Company (USA) Company Details
Table Allergan, Inc. (USA) Company Details
Table Novartis AG (Switzerland) Company Details
Table Novo Nordisk A/S (Denmark) Company Details
Table Pfizer, Inc. (USA) Company Details
Table Sanofi S.A (France) Company Details
Table Shionogi Inc. (USA) Company Details
Table Shire Pharmaceuticals Group Plc. (UK) Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Pediatric Drugs and Vaccines Value Chain
Table Typical Suppliers of Key Pediatric Drugs and Vaccines Raw Material
Table Pediatric Drugs and Vaccines Customers List
Table Pediatric Drugs and Vaccines Sales Channels
Table Pediatric Drugs and Vaccines Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Send an Enquiry

  • * :
  • * :
  • :
  • :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top